Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex

Human Molecular Genetics

Volumn 10, Issue 15, 2001, Pages 1563-1569

  Yamada, Hiroki ^a   Saito, Fumiaki ^a   Fukuta Ohi, Hiroko ^a   Zhong, Di ^a   Hase, Asako ^a   Arai, Ken ^a   Okuyama, Akira ^b   Maekawa, Ryuji ^c   Shimizu, Teruo ^a   Matsumura, Kiichiro ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; DYSTROGLYCAN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MEMBRANE PROTEIN; SARCOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN; CELL MEMBRANE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DESMOSOME; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART MUSCLE; HYPOTHESIS; KIDNEY; LUNG; MUSCLE ATROPHY; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; SKELETAL MUSCLE; SMOOTH MUSCLE;

ANIMALS; CATTLE; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; HUMANS; KIDNEY; LUNG; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; NEURONS; PROTEIN BINDING; RATS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0035878554     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
2. Biosynthesis of dystroglycan: Processing of a precursor propeptide
3. Dystroglycan: An extracellular matrix receptor linked to the cytoskeleton
4. Membrane organization of the dystrophin-glycoprotein complex
5. Molecular organization at the glycoprotein-complex-binding-site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin
6. Structural and functional analysis of the N-terminal extracellular region of β-dystroglycan
7. Laminin-induced clustering of dystroglycan on embryonic muscle cells: Comparison with agrin-induced clustering
8. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
9. A role for dystroglycan in basement membrane assembly
10. Laminin polymerization induces a receptor-cytoskeleton network
11. Dystroglycan in development and disease
12. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
13. Duchenne muscular dystrophy: Deficiency of dystrophin-associated proteins in the sarcolemma
14. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy
15. Beyond dystrophin: Current progress in the muscular dystrophies
16. From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy
17. Sarcoglycan complex: A muscular supporter of dystroglycan-dystrophin interplay?
18. Molecular basis of muscular dystrophies
19. Multiplex western blotting system for the analysis of muscular dystrophy patients
20. Characterization of dystroglycan-laminin interaction in peripheral nerve
21. Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells
22. Anomalous dystroglycan in carcinoma cell lines
23. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane
24. Laminin-nidogen complex. Extraction with chelating agents and structural characterization
25. Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor
26. Membrane-anchored metalloproteinase MDC9 has an α-secretase activity responsible for processing the amyloid precursor protein
27. Correlation of antiangiogenic and antitumor efficacy of N-biphenylo sulfonyl-phenlalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor
28. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: Application of film in situ zymography
29. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus
30. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae
31. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells
32. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells
33. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy
34. β-sarcoglycan: Genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate
35. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster
36. Molecular pathognesis of muscle degeneration in the δ-sarcoglycan-deficient hamster
37. Progressive muscular dystrophy in α-sarcoglycan-deficient mice
38. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer
39. Unusual laminin α2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy
40. Differential expression of dystrophin, utrophin and dystrophin associated proteins in peripheral nerve
41. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve
42. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
43. Induction and segregation of glial intermediate filament expression in the RT4 family of peripheral nervous system cell lines
44. A role of dystroglycan in Schwannoma cell adhesion to laminin